Although discounted cards might help relieve the burden of higher drug costs during the temporary, they don't handle the systemic difficulties driving up prescription price ranges while in the U.S. Broader plan adjustments could deal with the basis causes of increasing drug costs, for instance lack of transparency in pricing as well as part of inte